HBV Serological Profiles and Vaccination Status in People with HIV in the Transition to a Tenofovir-Sparing Era: Insights from a Large HIV Cohort - PubMed
3 hours ago
- #HBV immunity
- #HIV-HBV coinfection
- #tenofovir-sparing therapy
- 20% of people with HIV lacked protective HBV immunity.
- 45% of participants were on tenofovir-sparing ART regimens.
- 41% of those without HBV immunity were on tenofovir-sparing therapies.
- HBV serological profiles showed 52% had vaccine-induced immunity.
- Tenofovir recipients were younger, more often migrants, and had lower viral suppression rates.